Bone marrow transplantation experience for children with aplastic anemia

Area of Science:

• Hematology
• Immunology
• Pediatric Oncology

Background:

• Severe aplastic anemia is a life-threatening condition requiring bone marrow transplantation.
• Allogeneic bone marrow transplantation from HLA-identical family members is a potential curative option.
• Understanding factors influencing graft survival and rejection is crucial for improving outcomes.

Purpose of the Study:

• To evaluate the long-term survival and outcomes of pediatric patients undergoing allogeneic bone marrow transplantation for severe aplastic anemia.
• To identify factors associated with graft survival, rejection, and graft-versus-host disease.

Main Methods:

• Retrospective analysis of 81 children (22 months to 17 years) receiving HLA-identical allogeneic bone marrow grafts between 1971 and 1981.
• Patients were conditioned with cyclophosphamide, with variations in transfusion status, additional immunosuppression, and buffy coat cell administration.
• Multivariate analysis was used to identify significant prognostic factors.

Main Results:

• Overall survival was 70% (57/81) at the end of the study period.
• Untransfused patients conditioned with cyclophosphamide had an 83% survival rate (19/23) from 5 to 12 years.
• Absence of significant graft-versus-host disease was the only factor significantly associated with increased survival (P < .0001).
• Low bone marrow cell dose and positive mixed leukocyte culture response were linked to increased rejection (P < .05 and P < .0001, respectively).
• Grades II-IV acute graft-versus-host disease correlated with platelet refractoriness and donor/recipient sex differences (P < .05).
• Chronic graft-versus-host disease risk increased with acute graft-versus-host disease and buffy coat infusions (P < .01 and P < .025).

Conclusions:

• Allogeneic bone marrow transplantation can achieve long-term survival in children with severe aplastic anemia.
• Minimizing graft-versus-host disease is paramount for successful engraftment and improved survival.
• Pre-transplant conditioning, transfusion status, and donor-recipient characteristics significantly impact transplant outcomes.